Via Cantonale 77 6998 Tresa |
T.: +41 58 776 70 00 |
http://www.micro-sphere.com |
info@micro-sphere.com |
-
Main activities Drug Product CMO ● Drug Substance CMO ● Other CMO Activities ● -
Drug stages Pre-clinical ● Phase I - Phase III ● Registration ● Market ● Generic Plus (505B2) ● Generic ● -
Therapeutic areas Cancer supportive therapy ● Cardiology ● Cardiovascular ● CNS ● Dermatology ● Diabetes ● Endocronology ● Gastrointestinal ● Gynaecology ● Infertility ● Metabolism ● Oncology ● Ophtalmology ● Pain ● Respiratory ● Rheumatology ● -
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● MENA ● BRICS ○ ASEAN ● Australia ● India ● Japan ● -
Drug product forms Aerosol ● Inhaler ● Injectable ○ Oral (solid) ● Oral (liquid) ● Spray ● Topical ● -
Drug substance type APIs (1-10kgs/batch) ● APIs (20-200kgs/batch) ● APIs (>200kgs/batch) ○ HPAI 10-100g/batch ● HPAI 0.2-5kgs/batch ● HPAI 6-20kgs/batch ● HPAI >20kgs/batch ● HPAI Cat. 3 safebridge ● Antibiotics ○ Steroids ● -
Other activities (non pharma) Analytical Services ● Cosmetics ● Medical Devices ● Medical Food ● Natural Products ● Nutraceuticals ● Pre-formulation ● -
Other CMO activities Analytical Services ● Co-development ● Micronization ● Pre-formulation ● Spray-Drying ● Other ●
Linkedin